Home > Boards > US OTC > Biotechs > NorthWest Biotherapeutics Inc. (NWBO)

Based on these quotes, apart from the past

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Emergcy Member Profile
 
Followed By 31
Posts 2,450
Boards Moderated 0
Alias Born 05/13/07
160x600 placeholder
CEO Presenting on the First Emerging Growth / Investors Hub Joint Conference on July 21 InvestorsHub NewsWire - 7/19/2021 7:00:00 AM
CEO Presenting on the Emerging Growth / Investors Hub Joint Conference Tomorrow.  Register Now InvestorsHub NewsWire - 7/6/2021 7:00:00 AM
Sino United (OTC Pink: SUIC) $200 Million Commitment, Signs with Suntech, the Largest Taiwan O2O Company. InvestorsHub NewsWire - 6/30/2021 7:30:00 AM
CEO Presenting on the First Emerging Growth / Investors Hub Joint Conference Tomorrow!  Register Now InvestorsHub NewsWire - 6/22/2021 7:00:00 AM
CEO's Presenting at Emerging Growth Conference Virtually This Week InvestorsHub NewsWire - 6/7/2021 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/24/2021 4:35:22 PM
Northwest Bio gaining attention as investors await phase 3 GBM data Seeking Alpha - 5/24/2021 11:16:44 AM
CEO's Presenting at Emerging Growth Conference Virtually This Week InvestorsHub NewsWire - 5/24/2021 7:03:10 AM
IQST Signals BUY InvestorsHub NewsWire - 5/20/2021 9:43:19 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/17/2021 5:17:07 PM
CEO Presenting at Emerging Growth Conference Virtually This Week InvestorsHub NewsWire - 5/11/2021 7:00:00 AM
Nightfood, Inc. (OTCQB: NGTF) Joins Pepsico (NYSE: PEP), Unilever (NYSE: UL) and Bayer at Event InvestorsHub NewsWire - 5/5/2021 6:28:08 AM
Nightfood, Inc. (OTCQB: NGTF) in Walmart (NYSE: WMT) Coast to Coast over 1,000 Locations InvestorsHub NewsWire - 4/20/2021 7:09:50 AM
Annual Report (10-k) Edgar (US Regulatory) - 3/31/2021 4:56:16 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/5/2021 8:32:22 AM
Emerging Growth Conference 2 Announced for March 3, 2021 Niche Companies in Technology, AR, eCommerce, Beverage and more .... InvestorsHub NewsWire - 3/1/2021 6:28:27 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/26/2021 4:55:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/19/2021 4:07:42 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 1/15/2021 7:21:09 AM
The FDA Calendar Review Dates Can Play a Big Role in Timing Your Trades, But Not the Way You May Think InvestorsHub NewsWire - 1/7/2021 8:00:00 AM
Biotech Companies; Recent Milestones and Potential Upside InvestorsHub NewsWire - 12/22/2020 8:05:00 AM
TNS is on the Hunt for the Next OTC Home Run Stock, Feature Report InvestorsHub NewsWire - 11/30/2020 8:20:00 AM
Immune Therapeutics, Inc. Spinoff Cytocom, Inc. Appoints BioPharm Industry Veteran as New Chief Operating Officer InvestorsHub NewsWire - 11/11/2020 9:11:00 AM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 11/10/2020 4:58:13 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/2/2020 2:16:52 PM
Emergcy   Wednesday, 06/16/21 04:59:23 PM
Re: flipper44 post# 384833
Post # of 391153 
Based on these quotes, apart from the past data, the data have to be good otherwise, if bad, they would have to publish them as it would be material information.
Why is the share price under pressure when we have such convincing derisking info about the company?
Anyone who has an explanation for it? Thanks!

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences